跨越障碍:PEGylated金纳米颗粒作为阿尔茨海默病中siRNA输送的有希望的输送工具
Elżbieta Okła1,2, Marcin Hołota3, Sylwia Michlewska4
1Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
Biomedicines
|September 27, 2025
概括
两个基化黄金纳米颗粒显示出通过脑血屏障传递治疗性siRNA的前景. 这些纳米颗粒被发现对人类大脑内皮细胞,星球细胞和细胞周细胞是安全的,这表明它们有可能治疗神经退行性疾病.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 神经科学是一个神经科学.
背景情况:
- 像阿尔茨海默氏症这样的神经退行性疾病在全球范围内正在增加.
- 目前的治疗方法是有限的,因为大脑-血液屏障限制了药物获取.
- 开发有效的药物输送系统对于治疗这些疾病至关重要.
研究的目的:
- 评估两个化黄金纳米粒子 (AuNP14a和AuNP14b) 作为治疗小干扰RNA (siRNA) 的载体.
- 评估这些纳米颗粒对人类大脑内皮细胞 (HBEC-5i) 细胞功能的影响.
主要方法:
- 与siRNA复合的AuNP14a和AuNP14b与HBEC-5i细胞进行了化.
- 进行基因毒性测试以评估DNA损伤.
- 测量了反应性氧物种 (ROS) 生产和线粒体膜潜力.
- 细胞毒性测定是在星细胞和细胞周细胞上进行的.
主要成果:
- 这些纳米粒子被HBEC-5i细胞成功地内化并定位在细胞质中.
- 没有观察到DNA损伤,表明没有基因毒性.
- 细胞对纳米颗粒的管理表现出适应性反应,对线粒体功能没有显著的负面影响.
- 测试的纳米颗粒在星细胞和细胞周细胞中显示出生物安全性,这些细胞是血脑屏障的关键组成部分.
结论:
- AuNP14a和AuNP14b是安全有效的纳米载体,可以提供治疗性核酸.
- 这些纳米粒子显示出克服生物障碍的潜力,包括脑血屏障.
- 这项研究为开发神经退行性疾病的新疗法提供了有希望的途径.
相关概念视频
02:30siRNA - Small Interfering RNAs
18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
01:22Alzheimer's Disease: Treatment
824
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
824